Esidrex Tab 25 mg

Country: Jordan

Language: English

Source: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Active ingredient:

Hydrochlorothiazide 25 mg

Available from:

شركة مستودع الأدوية الأردني - The Jordan Drugstore Co

ATC code:

C03AA03

INN (International Name):

Hydrochlorothiazide 25 mg

Dosage:

25 mg

Units in package:

20

Manufactured by:

Novartis Faramceutica Barbera (اسبانيا)

Product summary:

2.02 :سعر الجمهور + الضريبة

Patient Information leaflet

ESIDREX
®
COMPOSITION
_Active substance: _Hydrochlorothiazide
_Excipients: _Lactose monohydrate, wheat starch, talc, silica,
colloidal anhydrous, magnesium stearate.
Information might differ in some countries.
PHARMACEUTICAL FORM AND QUANTITY OF ACTIVE SUBSTANCE PER UNIT
Scored tablets of 25 mg
INDICATIONS / POTENTIAL USES
_Hypertension: _As monotherapy and in combination with other
antihypertensives.
_Heart failure._
_Oedema _due to heart failure or mild to moderate renal or hepatic
impairment.
_Nephrogenic diabetes insipidus._
_Idiopathic hypercalciuria and prevention of recurrent calcium oxalate
calculi. _
DOSAGE / ADMINISTRATION
The dose is individualized depending on the condition and the
patient’s response. The dose can be
administered once daily as a single dose, which is best taken in the
morning with breakfast, or in two
divided doses. The tablets can be taken with or without food.
In the case of long-term therapy, the lowest dose compatible with
maintenance of optimum effect
should be given, particularly in elderly patients.
_Hypertension_
_Adults: _The starting dose is usually 25-50 mg/day, taken in the
morning or in two divided doses. For
long-term treatment, 12.5-25 mg every morning is often sufficient. If
the decrease in blood pressure
proves inadequate, combined treatment with another antihypertensive
drug is recommended. This
way the dose of each substance can often be kept lower. Sodium and/or
volume depletion should be
corrected prior to the use of Esidrex in combination with an ACE
inhibitor or an angiotensin receptor
blocker (ARB), or a direct renin inhibitor (DRI), or the treatment
should start under close medical
supervision.
_Heart failure and oedema _
_Adults: _The starting dose is 25-75 mg/day, given in 1-2 divided
doses. In isolated cases the starting
dose can be increased, but doses exceeding 100 mg rarely result in an
additional increase in efficacy.
Once the patient has begun to respond satisfactorily, 25 mg/day – or
possibly every other day – is
usually adequate for maintenanc